Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT6A | Q92794 | 12/20 | 0.58 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | KAT7 | O95251 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | KAT6B | Q8WYB5 | 1/20 | 0.53 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.53 |
| ▸ | KAT8 | Q9H7Z6 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5780621 | 0.82 | KAT6A (0.61) | KAT6ALMNAALDH1A1GAAKAT7 | |
| SCHEMBL3142366 | 0.81 | ALDH1A1 (0.66) | ALDH1A1GAAHPGDRAB9AKMT2A | |
| SCHEMBL3134061 | 0.81 | ALDH1A1 (0.62) | KAT6AALDH1A1GAAHPGDRAB9A | |
| SCHEMBL28676609 | 0.79 | ALDH1A1 (0.85) | LMNAALDH1A1GAAHPGDRAB9A | |
| SCHEMBL3171214 | 0.79 | ALDH1A1 (0.71) | KAT6AALDH1A1GAAHPGDRAB9A | |
| SCHEMBL6633162 | 0.78 | LMNA (0.68) | LMNAALDH1A1GAAHPGDRAB9A | |
| SCHEMBL6825949 | 0.76 | KAT6A (0.65) | KAT6ALMNAALDH1A1GAASMN1; SMN2 | |
| SCHEMBL28692846 | 0.75 | ALDH1A1 (0.88) | LMNAALDH1A1GAAHPGDRAB9A | |
| SCHEMBL8684777 | 0.75 | ALDH1A1 (0.48) | LMNAALDH1A1GAAHPGDRAB9A | |
| SCHEMBL3685286 | 0.75 | ALDH1A1 (0.68) | LMNAALDH1A1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | OY JUVANTIA PHARMA LTD. (FI) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | SSTR4, SSTR1, SSTR3 | KAT6A 3271/4885LMNA 3980/4885ALDH1A1 4124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.